Clinical Products Overview

CPSI, a global specialty pharmaceutical company, is committed to developing safe and effective therapeutics for patients. With a strong and robust pipeline of products, CPSI has a variety of technologies that focus in the area of women’s health, as well as several that fall outside this specialty. New product development is key at CPSI: the Company continues to invest significantly each year in early and late-stage clinical development.

Please see below for a list of products currently in clinical development.

• Misodel™ Vaginal Insert – Labor Induction
• CPSI-2364 – Psoriasis, Crohn’s Disease and ERCP-induced Pancreatitis
• Pilobuc™ Buccal Insert – Xerostomia (Dry Mouth)
• C-Vad™ Vaginal Insert – Bacterial Vaginosis
• Premis™ Vaginal Insert – Cervical Softening